PDE4B and Mental deterioration: Female monoallelic APPswe/PS1dE9 mice and WT littermates were injected daily with a PDE4B inhibitor, A33 (3 mg/kg), from postnatal 1–4 months, which is the time window that high levels of synapse loss are observed but before cognitive decline is to be expected (7–8 months) [45].